Practical articles organized by catalog use, documentation review, custom planning, and research procurement.
Choose a category to narrow the published guidance.
13 articles
TB-500 contains only the actin-binding region of thymosin beta-4, lacking other functional domains involved in cardiac repair, anti-scarring, and cell survival. This article explains each gap.
Read guidance →
Paradigm's customers also looked at certificates — but the certificates were forged. This article explains how to treat a COA as a claim to be checked, not as proof, and lays out a five-step verification process.
Read guidance →
CJC-1295 and Ipamorelin were both reviewed by the FDA’s compounding advisory committee in 2024 and voted down 0 to 12 and 0 to 13. This article reviews the 2023 classification, 2024 votes, the 2026 thaw they were skipped by, and current regulatory status.
Read guidance →
GLOW has three major unknowns: injected copper load lacks human data, TB-500 carries angiogenesis risk, and three pro-angiogenic signals have never been tested together. This article reviews each.
Read guidance →
In the Phase II monotherapy trial, 41–63% of participants reported GI adverse events versus 32% on placebo; with semaglutide that figure is around 80%. This article breaks down nausea, constipation, diarrhoea, injection-site reactions, fatigue and hypoglycaemia rates, and notes that the longest safety data still covers only 84 weeks.
Read guidance →
In June 2026, Australian health authorities recorded six cases of acute liver injury linked to gray-market products labeled retatrutide. This article explains the alert, the contaminant suspicion, and why the molecule itself cannot be simply blamed.
Read guidance →
PT-141 (bremelanotide) acts through brain melanocortin pathways, with a mechanism completely different from PDE-5 inhibitors. This article explains its pathway, FDA approval status, and notable side effects.
Read guidance →
Almost all information about BPC-157 comes from animal experiments. This article reviews the few human studies available, including ulcerative colitis, interstitial cystitis, and multiple sclerosis, and why these results are still insufficient to support firm conclusions.
Read guidance →
Antimicrobial peptides are the first line of defense in the human immune system. They carry a positive charge and can disrupt bacterial cell membranes within 5–10 minutes without harming electrically neutral human cells. This article explains the sources, structural features, and three antimicrobial mechanisms of antimicrobial peptides.
Read guidance →
A practical checklist for identifying a catalog record and giving the review team enough information to answer accurately.
Read guidance →
Understand the difference between a catalog statement, a mapped historical file, and documentation for the material currently being quoted.
Read guidance →
The sequence, modification, purity, quantity, analytical, destination, and timing details that make a custom request reviewable.
Read guidance →
A controlled way to compare identity, specification, evidence, destination requirements, and lead time before a purchase decision.
Read guidance →